Diltiazem |
Cardizem |
Diltiazem Systematic (IUPAC) name [2-(2-dimethylaminoethyl)-5-(4-methoxyphenyl) -3-oxo-6-thia-2-azabicyclo[5.4.0]undeca-7,9, 11-trien-4-yl]ethanoate Identifiers CAS number 42399-41-7 ATC code C08DB01 PubChem 39186 DrugBank APRD00473 Chemical data Formula C22H26N2O4S Mol. weight 414.519 g/mol Pharmacokinetic data Bioavailability 40% Metabolism Hepatic Half life 3-4.5 hours Excretion Renal Biliary Lactic (in lactiferous females) Therapeutic considerations ...
Wikipedia - [full article]
Diltiazem Clinical Trials
- Treatment of Preclinical Hypertrophic Cardiomyopathy With Diltiazem
ClinicalTrials.gov Identifier: NCT00319982 - Recruiting
Hypertrophic Cardiomyopathy
- The Effect of Concomitant Administration of Erythromycin and Diltiazem on CYP3A Activity in Healthy Volunteers
ClinicalTrials.gov Identifier: NCT00318201 - Completed
Healthy
- Interactions Between HIV Protease Inhibitors and Calcium Channel Blockers
ClinicalTrials.gov Identifier: NCT00039975 - Completed
HIV Infections; Cardiovascular Diseases; Hypertension
- Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM)
ClinicalTrials.gov Identifier: NCT00000556 - Completed
Arrhythmia; Atrial Fibrillation; Cardiovascular Diseases; Heart Diseases
- Asymptomatic Cardiac Ischemia Pilot (ACIP) Study
ClinicalTrials.gov Identifier: NCT00000478 - Completed
Cardiovascular Diseases; Coronary Disease; Heart Diseases; Myocardial Ischemia

Not Signed In -

